The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 18, 2025
Filed:
Aug. 17, 2020
Applicant:
Poltorak Technologies, Llc, Suffern, NY (US);
Inventor:
Alexander Poltorak, Monsey, NY (US);
Assignee:
Poltorak Technologies LLC, Pomona, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/30 (2018.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/029 (2006.01); A61B 5/0533 (2021.01); A61B 5/369 (2021.01); A61B 5/389 (2021.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61B 5/08 (2006.01); A61B 5/091 (2006.01);
U.S. Cl.
CPC ...
A61B 5/02055 (2013.01); A61B 5/0022 (2013.01); A61B 5/029 (2013.01); A61B 5/0533 (2013.01); A61B 5/369 (2021.01); A61B 5/389 (2021.01); A61B 5/6802 (2013.01); A61B 5/6847 (2013.01); A61B 5/7264 (2013.01); A61B 5/7275 (2013.01); A61B 5/746 (2013.01); G16H 50/30 (2018.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 5/02416 (2013.01); A61B 5/0816 (2013.01); A61B 5/091 (2013.01); A61B 5/7239 (2013.01); A61B 2503/40 (2013.01); A61B 2560/0257 (2013.01); A61B 2562/0247 (2013.01); A61B 2562/0257 (2013.01); A61B 2562/0271 (2013.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01);
Abstract
A method and device for analysis of sampled physiological parameters according to at least a second-order process over time, e.g., second-order differential equation or model, for use in therapeutic, diagnostic, or predictive health applications. The system may generate an alert regarding a present or predicted health abnormality. The biometric device may be implantable, wearable, contact or non-contact, and may communicate through a network, to send an alert. The system may further comprise an actuator or therapeutic device to perform an action based on the at least second-order process.